Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH, United States of America.
Healthcare Management, Franklin University, Columbus, Ohio, United States of America.
PLoS One. 2024 Jan 5;19(1):e0296062. doi: 10.1371/journal.pone.0296062. eCollection 2024.
There is a paucity of evidence on the association between satisfaction with quality of care and adherence to antidepressants.
To examine the association between patient satisfaction with healthcare and adherence to antidepressants.
A cohort study design was used to identify antidepressant users from the 2010-2016Medical Expenditure Panel Survey data, a national longitudinal complex survey study design on the cost and healthcare utilization of the noninstitutionalized population in the United States. The Consumer Assessment of Healthcare Providers and Systems were used to measure participants' satisfaction with access and quality of care, patient-provider communication and shared decision-making (SDM). Patients were considered satisfied if they ranked the quality of care at ≥9 (range: 0[worst]- 10[best]). Antidepressant adherence was measured based on medication refill and complete discontinuation. MEPS sampling survey-weighted multivariable-adjusted logistic regression models were used to calculate the odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between satisfaction and adherence to antidepressants. We tested for the potential presence of reverse associations by restricting the analysis to new users of antidepressants. The roles of patient-provider communication and SDM on the satisfaction-adherence association were examined through structural equation models (SEM).
Among 4,990 (weighted counts = 8,661,953) antidepressant users, 36% were adherent while 39% discontinued antidepressants therapy. Half of antidepressant users were satisfied with the healthcare received. Satisfied patients were 26% (OR = 1.26, 95%CI: 1.08, 1.47) more likely to adhere and 17% (OR = 0.83, 95%CI: 0.71, 0.96) less likely to discontinue, compared to unsatisfied antidepressant users. Patient satisfaction was also associated with higher odds (OR = 1.41, 95%CI: 1.06, 1.88) of adherence among a subgroup of new users of antidepressants. The SEM analysis revealed that satisfaction was a manifestation of patient-provider communication (β = 2.03, P-value<0.001) and SDM (β = 1.14, P-value<0.001).
Patient satisfaction is a potential predictor of antidepressant adherence. If our findings are confirmed through intervention studies, improving patient-provider communication and SDM could likely drive both patient satisfaction and adherence to antidepressants.
关于患者对医疗服务质量的满意度与抗抑郁药物治疗依从性之间的关联,目前的证据还比较匮乏。
研究患者对医疗服务的满意度与抗抑郁药物治疗依从性之间的关联。
本研究采用队列研究设计,从 2010-2016 年美国医疗支出面板调查(MEPS)数据中确定抗抑郁药使用者,该调查是一项针对美国非住院人群医疗成本和医疗服务利用情况的全国性纵向复杂调查研究。采用医疗保健提供者和系统消费者评估量表(CAHPS)衡量参与者对获取医疗服务和医疗服务质量、医患沟通和共享决策(SDM)的满意度。如果患者将医疗服务质量评为≥9 分(评分范围:0[最差]-10[最好]),则认为他们对医疗服务感到满意。抗抑郁药物的依从性是基于药物续开和完全停药来衡量的。采用 MEPS 抽样调查加权多变量调整逻辑回归模型计算满意度与抗抑郁药物治疗依从性之间的比值比(OR)及其 95%置信区间(CI)。通过限制仅对新使用抗抑郁药物的患者进行分析,以检测可能存在的反向关联。通过结构方程模型(SEM)研究患者-提供者沟通和 SDM 对满意度-依从性关联的作用。
在 4990 名(加权计数=8661953)抗抑郁药使用者中,36%的患者依从治疗,39%的患者停止了抗抑郁药物治疗。一半的抗抑郁药使用者对所接受的医疗服务感到满意。与不满意的抗抑郁药使用者相比,满意的患者更有可能(OR=1.26,95%CI:1.08,1.47)坚持治疗,更不可能(OR=0.83,95%CI:0.71,0.96)停药。在新使用抗抑郁药物的患者亚组中,患者满意度与更高的依从性可能性(OR=1.41,95%CI:1.06,1.88)相关。SEM 分析显示,满意度是医患沟通(β=2.03,P 值<0.001)和 SDM(β=1.14,P 值<0.001)的表现。
患者满意度是抗抑郁药物治疗依从性的一个潜在预测因素。如果通过干预研究得到证实,改善医患沟通和 SDM 可能会提高患者满意度并促进患者对抗抑郁药物的依从性。